Venzon DJ - Search Results

1

Systemic immune changes accompany combination treatment with immunotoxin LMB-100 and nab-paclitaxel.

Pegna GJ, Lee MJ, Peer CJ, Ahmad MI, Venzon DJ, Yu Y, Yuno A, Steinberg SM, Cao L, Figg WD, Donahue RN, Hassan R, Pastan I, Trepel JB, Alewine C. Pegna GJ, et al. Among authors: venzon dj. Cancer Med. 2023 Feb;12(4):4236-4249. doi: 10.1002/cam4.5290. Epub 2022 Oct 8. Cancer Med. 2023. PMID: 36208017 Free PMC article.

2

CD4 count and the risk for death in patients infected with HIV receiving antiretroviral therapy.

Yarchoan R, Venzon DJ, Pluda JM, Lietzau J, Wyvill KM, Tsiatis AA, Steinberg SM, Broder S. Yarchoan R, et al. Among authors: venzon dj. Ann Intern Med. 1991 Aug 1;115(3):184-9. doi: 10.7326/0003-4819-115-3-184. Ann Intern Med. 1991. PMID: 1676252 Clinical Trial.

3

Lack of in vitro synergy between etoposide and cis-diamminedichloroplatinum(II).

Tsai CM, Gazdar AF, Venzon DJ, Steinberg SM, Dedrick RL, Mulshine JL, Kramer BS. Tsai CM, et al. Among authors: venzon dj. Cancer Res. 1989 May 1;49(9):2390-7. Cancer Res. 1989. PMID: 2706626

4

Pharmacologic variables associated with the development of neurologic toxicity in patients treated with suramin.

Bitton RJ, Figg WD, Venzon DJ, Dalakas MC, Bowden C, Headlee D, Reed E, Myers CE, Cooper MR. Bitton RJ, et al. Among authors: venzon dj. J Clin Oncol. 1995 Sep;13(9):2223-9. doi: 10.1200/JCO.1995.13.9.2223. J Clin Oncol. 1995. PMID: 7666080 Clinical Trial.

5

Phase I study of phenylacetate administered twice daily to patients with cancer.

Thibault A, Samid D, Cooper MR, Figg WD, Tompkins AC, Patronas N, Headlee DJ, Kohler DR, Venzon DJ, Myers CE. Thibault A, et al. Among authors: venzon dj. Cancer. 1995 Jun 15;75(12):2932-8. doi: 10.1002/1097-0142(19950615)75:12<2932::aid-cncr2820751221>3.0.co;2-p. Cancer. 1995. PMID: 7773944 Clinical Trial.

6

Taxol in combination with doxorubicin or etoposide. Possible antagonism in vitro.

Hahn SM, Liebmann JE, Cook J, Fisher J, Goldspiel B, Venzon D, Mitchell JB, Kaufman D. Hahn SM, et al. Cancer. 1993 Nov 1;72(9):2705-11. doi: 10.1002/1097-0142(19931101)72:9<2705::aid-cncr2820720930>3.0.co;2-k. Cancer. 1993. PMID: 8104682

7

A phase I and pharmacokinetic study of intravenous phenylacetate in patients with cancer.

Thibault A, Cooper MR, Figg WD, Venzon DJ, Sartor AO, Tompkins AC, Weinberger MS, Headlee DJ, McCall NA, Samid D, et al. Thibault A, et al. Among authors: venzon dj. Cancer Res. 1994 Apr 1;54(7):1690-4. Cancer Res. 1994. PMID: 8137283 Clinical Trial.

8

In vitro effect of gallium nitrate when combined with ketoconazole in the prostate cancer cell line PC-3.

Dixon SC, Zalles A, Giordano C, Lush RM, Venzon D, Reed E, Figg WD. Dixon SC, et al. Cancer Lett. 1997 Feb 26;113(1-2):111-6. doi: 10.1016/s0304-3835(97)04603-x. Cancer Lett. 1997. PMID: 9065809

9

Elevated carcinoembryonic antigen in patients with androgen-independent prostate cancer.

Feuer JA, Lush RM, Venzon D, Duray P, Tompkins A, Sartor O, Figg WD. Feuer JA, et al. J Investig Med. 1998 Feb;46(2):66-72. J Investig Med. 1998. PMID: 9549229

10

A phase I trial of continuous hyperthermic peritoneal perfusion with tumor necrosis factor and cisplatin in the treatment of peritoneal carcinomatosis.

Bartlett DL, Buell JF, Libutti SK, Reed E, Lee KB, Figg WD, Venzon DJ, Alexander HR. Bartlett DL, et al. Among authors: venzon dj. Cancer. 1998 Sep 15;83(6):1251-61. Cancer. 1998. PMID: 9740093 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

425 results

Search Page

Filters